Coffee and coronary heart disease.

Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J (1994) 1.60

Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health (1999) 1.31

Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia (2009) 0.98

The cholesterol-raising factor from coffee beans. J R Soc Med (1996) 0.83

Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. Am Heart J (2009) 0.83

The effects of coffee on serum lipids and blood pressure in a UK population. J R Soc Med (1994) 0.81

Long-term, moderate coffee consumption is associated with lower prevalence of diabetes mellitus among elderly non-tea drinkers from the Mediterranean Islands (MEDIS Study). Rev Diabet Stud (2007) 0.77

Quality of systematic reviews of observational nontherapeutic studies. Prev Chronic Dis (2010) 0.77

Caffeine under examination--a passing grade. West J Med (1992) 0.75

Coffee and coronary heart disease. Arch Intern Med (1993) 0.75

Cognitive Performance and Mood Following Ingestion of a Theacrine-Containing Dietary Supplement, Caffeine, or Placebo by Young Men and Women. Nutrients (2015) 0.75

Effect of caffeine on the risk of coronary heart disease- A re-evaluation. Indian J Clin Biochem (2007) 0.75

Assessment of priority for coronary revascularisation procedures. Revascularisation Panel and Consensus Methods Group. Lancet (1990) 4.98

Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med (2000) 1.80

Report on activities and attitudes of organizations active in the clinical practice guidelines field. CMAJ (1995) 1.76

Clinical and population epidemiology: beyond sibling rivalry? J Clin Epidemiol (1990) 1.49

Technology assessment and cost-effectiveness analysis: misguided guidelines? CMAJ (1993) 1.33

Mismatch of coronary risk and treatment intensity under the National Cholesterol Education Program guidelines. J Gen Intern Med (1992) 1.17

Coronary thrombolysis--clinical guidelines and public policy: results of an Ontario practitioner survey. CMAJ (1990) 1.07

Placing patients in the queue for coronary revascularization: evidence for practice variations from an expert panel process. Am J Public Health (1990) 1.05

Chest wall pain after aortocoronary bypass surgery using internal mammary artery graft: a new pain syndrome? Heart Lung (1989) 0.92

A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol (2005) 0.88

Aspirin and fibrinolysis. Lancet (1988) 0.83

Arthroscopic synovectomy of the knee for rheumatoid arthritis. Arthroscopy (1991) 0.83

Single fiber EMG in the frontalis muscle in ocular myasthenia: specificity and sensitivity. Muscle Nerve (1992) 0.81

Usefulness of single fiber EMG for distinguishing neuromuscular from other causes of ocular muscle weakness. Can J Neurol Sci (1994) 0.81

Determinants of left ventricular mass in early hypertension. Am J Hypertens (1998) 0.76

What should be done about asymptomatic hypercholesterolaemia? BMJ (1991) 0.75

Meta-analyses of the effects of thrombolysis and aspirin on clinical outcomes. J Am Coll Cardiol (1992) 0.75

Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis. Hepatogastroenterology (1991) 0.75